Episode

Episode 489: Live Podcast From EAU

Podcast
The Uromigos
Published
Mar 16, 2026
Duration seconds
2898
Processing state
not_requested
Canonical source
https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-489-Live-Podcast-From-EAU-e3gguqg
Audio
https://anchor.fm/s/13347ea8/podcast/play/116996368/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-2-16%2F420114054-44100-2-d123919aeda97.mp3
JSON
/v1/public/podcasts/the-uromigos-1214845/episodes/episode-489-live-podcast-from-eau
Markdown
/podcast/the-uromigos-1214845/episode-489-live-podcast-from-eau.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-489-live-podcast-from-eau/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-uromigos-1214845/episode-489-live-podcast-from-eau.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Tom and Brian take the stage in London for a live podcast. With the help of several special guests from the audience, they discuss management of peri-operative therapy in bladder cancer (notably in patients who may refuse cystectomy) and also the emerging pembro plus belzutifan data in adjuvant RCC.